Any feedback?
Please rate this page
(search_result.php)
(0/150)

BRENDA support

Refine search

Search General Information

show results
Don't show organism specific information (fast!)
Search organism in taxonomic tree (slow, choose "exact" as search mode, e.g. "mammalia" for rat,human,monkey,...)
(Not possible to combine with the first option)
Refine your search

Search term:

Results 1 - 10 of 15 > >>
EC Number General Information Commentary Reference
Show all pathways known for 2.7.7.60Display the word mapDisplay the reaction diagram Show all sequences 2.7.7.60evolution structure, function and mechanism of Plasmodium IspD homologs from their evolutionary imprints, e.g. Theileria annulata. Structure-based phylogeny for PlIspD homologues, constructed by using the maximum likelihood algorithm with the Dayhoff model structure and structure motifs prediction and characterization of PlIspD homologues, overview -, 761602
Show all pathways known for 2.7.7.60Display the word mapDisplay the reaction diagram Show all sequences 2.7.7.60evolution the enzyme is a member of the cytidylyltransferase family of enzymes that utilize cytidine 5'-triphosphate (CTP) to synthesize molecules that are typically precursors to membrane phospholipids 737438
Show all pathways known for 2.7.7.60Display the word mapDisplay the reaction diagram Show all sequences 2.7.7.60malfunction the inhibition of DXR (EC 1.1.1.267, MEP synthase) dramatically reduces IspD function in cells. Phosphonic acid antibiotic fosmidomycin is a substrate mimic and inhibitor of DXR. The inhibition of downstream enzyme IspD is also metabolically apparent in fosmidomycin-treated cells, although IspD homologues are not directly inhibited by fosmidomycin in vitro -, 760261
Show all pathways known for 2.7.7.60Display the word mapDisplay the reaction diagram Show all sequences 2.7.7.60malfunction the inhibition of DXR (EC 1.1.1.267, MEP synthase) dramatically reduces IspD function in cells. Phosphonic acid antibiotic fosmidomycin is a substrate mimic and inhibitor of DXR.13 The inhibition of downstream enzyme IspD is also metabolically apparent in fosmidomycin-treated cells, although IspD homologues are not directly inhibited by fosmidomycin in vitro. 1R,3S-MMV008138-treated parasites supplemented with 0.2 mM isopentenyl diphosphate (IPP) are viable, but 1R,3S-MMV008138 treatment of such IPP-rescued cells still results in a significant reduction in methylerythritol cyclic diphosphate (MEcPP) levels, the most distal MEP metabolite detected 760261
Show all pathways known for 2.7.7.60Display the word mapDisplay the reaction diagram Show all sequences 2.7.7.60metabolism the MEP cytidylyltransferase, or IspD catalyzes the second committed step of the methyl erythritol phosphate (MEP) pathway. The MEP pathway is essential for the production of isoprenoids -, 760333
Show all pathways known for 2.7.7.60Display the word mapDisplay the reaction diagram Show all sequences 2.7.7.60more molecular dynamics simulation, homology PvIspD structure prediction by comparative modeling technique using the Escherichia coli IspD crystal structure (PDB ID 1I52) as template, and three-dimensional modeling of PvIspD. The conserved domain (NCBI) analysis of translated sequences (619 a.a.) shows the presence of Glycosyl transferase family A (GT-A) domain spanning the amino acid residues 191-558. The two signature motifs of the IspD proteins in this domain viz. GXG and [IVT]-[LIVMC]-[IVT]-[HS]-D-[SGAV]-[AV]-R are also observed in PVX_081425 and all Indian PvIspD sequences by PROSITE as 199GXG201 and 424ILVHDGAR431. Key residues R431 and K548 form the salt bridge with CTP -, 761199
Show all pathways known for 2.7.7.60Display the word mapDisplay the reaction diagram Show all sequences 2.7.7.60more the concerted movements of the P-loop and loops close to the active site are essential in the reaction catalyzed by IspD. The intact P-loop is observed in the apo structure of IspD enzyme. The P-loop comprising residues 8-21 in the apo form I are refined satisfactorily, the B-factor of 30 A2 is almost the same as the average B-factor of all the protein atoms, this loop is highly conserved in the IspD enzymes. BsIspD structure, overview. The active site of BsIspD is covered by P-loop; hydrogen bonding interactions are formed between P-loop and adjacent residues. Upon CTP binding, conformational changes are observed on P-loop, L1-loop and L2-loop. The N-terminal half of the P-loop flips upward from active pocket and the C-terminal half flips down right, the active pocket is open to accommodate the CTP. A cleft is formed between L1-loop and P-loop, favoring for the binding of the cytosine base of CTP, at the same time, the residue Arg15 in the P-loop forms hydrogen bond to the residue Thr211 in L2-loop -, 762421
Show all pathways known for 2.7.7.60Display the word mapDisplay the reaction diagram Show all sequences 2.7.7.60more the enzyme's catalytic pocket, which actively participates in interaction with ligands, mainly consists of polar amino acid residues, three-dimensional modeling of the IspD protein -, 761358
Show all pathways known for 2.7.7.60Display the word mapDisplay the reaction diagram Show all sequences 2.7.7.60more the Pf ISPD genetic locus is refractory to disruption in malaria parasites, providing independent genetic validation for efforts targeting this enzyme 760261
Show all pathways known for 2.7.7.60Display the word mapDisplay the reaction diagram Show all sequences 2.7.7.60physiological function 2-C-methyl-D-erythritol 4-phosphate cytidyltransferase (IspD) is an essential enzyme in the mevalonate-independent pathway of isoprenoid biosynthesis. This enzyme catalyzes 2-C-methyl-derythritol 4-phosphate (MEP) and cytosine triphosphate (CTP) to 4-diphosphocytidyl-2-C-methyl-derythritol (CDPME) and diphosphate -, 762421
Results 1 - 10 of 15 > >>